Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
出版年份 2017 全文链接
标题
Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 12, Pages 2671
出版商
MDPI AG
发表日期
2017-12-12
DOI
10.3390/ijms18122671
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel in vivo
- (2017) Tsung-Chieh Shih et al. MOLECULAR CANCER THERAPEUTICS
- Galectin-1 is a useful marker for detecting neoplastic squamous cells in oral cytology smears
- (2016) Yuri Noda et al. HUMAN PATHOLOGY
- Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
- (2016) P-F Zhang et al. Cell Death & Disease
- Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia
- (2015) Nathan A. Koonce et al. PLoS One
- Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
- (2014) N. Martinez-Bosch et al. CANCER RESEARCH
- OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
- (2014) Lucile Astorgues-Xerri et al. EUROPEAN JOURNAL OF CANCER
- Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer
- (2013) Ruud P. M. Dings et al. INVESTIGATIONAL NEW DRUGS
- Blood Outgrowth Endothelial Cells Increase Tumor Growth Rates and Modify Tumor Physiology: Relevance for Therapeutic Targeting
- (2013) Jonathan Pagan et al. Cancers
- Abstract 4520: Targeting galectin-1 with PTX-008 inhibits invasion, tumor growth and metastasis in human carcinoma models
- (2012) Lucile Astorgues-Xerri et al. CANCER RESEARCH
- Abstract 1926: Antitumor and antiangiogenic effects of OTX-008, a novel calyx[4]arene, are mediated by galectin-1 inhibition in human tumor xenograft models
- (2012) Lucile Astorgues-Xerri et al. CANCER RESEARCH
- Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin-1 and induction of poor prognosis factors
- (2012) Jaroslav Valach et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
- (2012) Ruud P. M. Dings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abstract B166: Effects of PTX-008, a non-peptidic topomimetic targeting galectin-1 in human epithelial cancer cells
- (2012) L. Astorgues-Xerri et al. MOLECULAR CANCER THERAPEUTICS
- Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 Infection
- (2011) Christian St-Pierre et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- Taloside Inhibitors of Galectin-1 and Galectin-3
- (2011) Patrick M. Collins et al. Chemical Biology & Drug Design
- Enhancement of T-cell-Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
- (2011) R. P. M. Dings et al. CLINICAL CANCER RESEARCH
- Antibody validation
- (2010) Jennifer Bordeaux et al. BIOTECHNIQUES
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started